A panel discussion that took place at the 2023 Fall Clinical Dermatology Conference focused on the importance of information to treat both vitiligo and atopic dermatitis. Atopic dermatitis (AD) and ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease ...

Like many other chronic health conditions, vitiligo is often misunderstood—and due to the visible symptoms it causes, it’s undeniably stigmatized. Vitiligo is a chronic autoimmune condition that ...

Advances in understanding the pathophysiology of vitiligo are transforming patient management, offering new hope for individuals with mild, moderate, and even severe forms of the disease, delegates ...

ATLANTA - At 57, Perry Whaley has been living with vitiligo, an autoimmune disorder that has caused him to lose pigment in his skin, for more than half his life. Whaley said, if he had been offered a ...

Think about a world where a light is restoring your skin’s lost color. Red light therapy lamp is becoming popular for skin pigmentation treatment among people with vitiligo. The common skin condition, ...

The FDA approved Incyte’s Opzelura topical cream, known as ruxolitinib, to treat vitiligo in patients 12 and older The U.S. Food and Drug Administration has granted approval to a topical treatment for ...

The FDA granted Incyte, a Wilmington, Del.-based pharmaceutical company, the first approval for a vitiligo treatment after finding positive results in its phase 3 trials July 18. Vitiligo is a chronic ...

Please provide your email address to receive an email when new articles are posted on . More than 72% of patients were either somewhat or very satisfied with their treatment outcomes. Over 84% of ...

Ruxolitinib cream is the first FDA-approved JAK inhibitor for skin repigmentation in people with vitiligo, paving the way for additional oral and topical JAK inhibitors to treat this autoimmune ...

is your neighborhood reporter San Patricio and Aransas County. CORPUS CHRISTI, Texas — It's estimated more than 1 million Americans suffer from vitiligo, a disease that causes discolored patches of ...